Nephro Care, a company in the Hospital industry, reported revenue of ₹33 crore and net profit of ₹2.76 crore for the September 2026 quarter.
Nephro Care (NSE: NEPHROCARE-SM) closed at ₹91.95 on 20 Nov 2026. Its market capitalisation is ₹152 crore and it trades at 26.2 times earnings.
Incorporated in 2014, Nephro Care India Ltd is a healthcare provider that specializes in the treatment of kidney- related diseases
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.